LiveDNA empowers researchers, scholars, editors, reviewers, publishers, and institutions with a trusted digital identity and comprehensive professional profile.
Wei Zhang

Wei Zhang

LiveDNA ID: 86.6280
23 Publications
0 Editorial Roles
0 Projects

Education

Academic Background
  • Ph.D. Central South University, China Pharmacology | Completed: 2006

Publications (23)

Selected Scholarly Contributions
Effect of a single-dose rifampin on the pharmacokinetics of pitavastatin in healthy volunteers.
Chen, Y., W. Zhang, W.H. Huang, Z.R. Tan, Y.C. Wang, X. Huang and H.H. Zhou,
Eur. J. Clin. Pharmacol., | Journal Article
10.1007/s00228-013-1554-0
Self Wei Zhang
2013
Current pharmacogenomic studies on hERG potassium channels.
He, F.Z., H.L. McLeod and W. Zhang,
Trends Mol. Med., | Journal Article
10.1016/j.molmed.2012.12.006
Self Wei Zhang
2013
Rapid clinical induction of bupropion hydroxylation by metamizole in healthy Chinese men.
Qin, W.J., W. Zhang, Z.Q. Liu, X.P. Chen and Z.R. Tan et al.,
Br. J. Clin. Pharmacol., | Journal Article
10.1111/j.1365-2125.2012.04304.x
Self Wei Zhang
2012
Pharmacokinetic interactions between ilaprazole and clarithromycin following ilaprazole, clarithromycin and amoxicillin triple therapy.
Cao, S., G. Zhou, D.S.O. Yang, H. Wu and K. Xiao et al.,
Acta Pharmacol. Sin., | Journal Article
10.1038/aps.2012.64
Self Wei Zhang
2012
Effects of Ginkgo biloba extracts on pharmacokinetics and efficacy of atorvastatin based on plasma indices.
Guo, C.X., Q. Pei, J.Y. Yin, X.D. Peng and B.T. Zhou et al.,
Xenobiotica, | Journal Article
10.3109/00498254.2012.661100
Self Wei Zhang
2012
Effects of natural products on the function of human organic anion transporting polypeptide 1B1.
Wu, L.X., C.X. Guo, Q. Qu, J. Yu and W.Q. Chen et al.,
Xenobiotica, | Journal Article
10.3109/00498254.2011.623796
Self Wei Zhang
2012
Inhibition of the organic anion-transporting polypeptide 1B1 by quercetin: An in vitro and in vivo assessment.
Wu, L.X., C.X. Guo, W.Q. Chen, G. Wang and L. Fan et al.,
Br. J. Clin. Pharmacol., | Journal Article
10.1111/j.1365-2125.2011.04150.x
Self Wei Zhang
2012
Translating pharmacogenomics into personalized medicine and drug development.
Zhang, W., T.Y.K. Chan, L. Fan, Y. Guo and H.H. Zhou,
Pers. Med., | Journal Article
10.2217/pme.11.78
Self Wei Zhang
2012
Pharmacogenetics of drugs withdrawn from the market.
Zhang, W., M.W. Roederer, W.Q. Chen, L. Fan and H.H. Zhou,
Pharmacogenomics, | Journal Article
10.2217/pgs.11.137
Self Wei Zhang
2012
Pharmacogenetics and rational drug use around the world.
Roederer, M.W., F. Sanchez-Giron, K. Kalideen, W. Kudzi, H.L. McLeod and W. Zhang,
Pharmacogenomics, | Journal Article
10.2217/pgs.11.17
Self Wei Zhang
2011
The pregnane X receptor agonist St John's wort has no effects on the pharmacokinetics and pharmacodynamics of repaglinide.
Fan, L., G. Zhou, D. Gou, Y.L. Liu and W.Q. Chen et al.,
Clin. Pharmacolkinet, | Journal Article
10.2165%2F11587310-000000000-00000
Self Wei Zhang
2011
Identification of ilaprazole metabolites in human urine by HPLC-ESI-MS/MS and HPLC-NMR experiments.
Zhou, G., S. Shi, W. Zhang, Z. Tan and Y. Chen et al.,
Biomed. Chromatogr., | Journal Article
10.1002/bmc.1416
Self Wei Zhang
2010
Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism.
He, Y.J., W. Zhang, Y. Chen, D. Guo and J.H. Tu et al.,
Clin. Chim. Acta, | Journal Article
10.1016/j.cca.2009.04.003
Self Wei Zhang
2009
HNF1a inhibitor ursodeoxycholic acid (UDCA) influences pharmacokinetics of the OATP1B1 substrate rosuvastatin and bilirubin.
He, Y.J., W. Zhang, J.H. Tu, J. Kirchheiner and Y. Chen et al.,
Drug Metab. Dispos., | Journal Article
Self Wei Zhang
2008
Pharmacokinetics of the new proton pump inhibitor ilaprazole in Chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypes.
Li, Y., W. Zhang, D. Guo, G. Zhou, H. Zhou and Z. Xiao,
Clin. Chim. Acta, | Journal Article
10.1016/j.cca.2008.02.003
Self Wei Zhang
2008
Inhibition of ADP-induced platelet aggregation by clopidogrel is related to CYP2C19 genetic polymorphisms.
Chen, B.L., W. Zhang, Q. Li, Y.L. Li and Y.J. He et al.,
Clin. Exp. Pharmacol. Physiol., | Journal Article
10.1111/j.1440-1681.2008.04915.x
Self Wei Zhang
2008
Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: A randomized, single-blind, placebo-controlled, crossover study.
Zhang, W., S. Deng, X.P. Chen, G. Zhou and H.T. Xie et al.,
Clin. Ther., | Journal Article
Self Wei Zhang
2008
The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1.
Fan, L., W. Zhang, D. Gou, Z.R. Tan and P. Xu et al.,
Clin. Pharmacol. Ther., | Journal Article
Self Wei Zhang
2007
OATP1B1 polymorphism is a major determinant of serum bilirubin level but not associated with rifampicin-mediated bilirubin elevation.
Zhang, W., Y.J. He, G. Zhou, L. Fan and Q. Li et al.,
Clin. Exp. Pharmacol. Physiol., | Journal Article
10.1111/j.1440-1681.2007.04798.x
Self Wei Zhang
2007
Metabolisms of lornoxicam and its major metabolite 5'-hydroxy lornoxicam related to CYP2C9 Genotype in healthy subjects.
Liu, Y.L., W. Zhang, Z.R. Tan, D.S. Ouyang and C.H. Luo et al.,
Clin. Chim. Acta, | Journal Article
Self Wei Zhang
2006
Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males.
Zhang, W., B.N. Yu, Y.J. He, L. Fan and Q. Li et al.,
Clin. Chim. Acta, | Journal Article
10.1016/j.cca.2006.05.010
Self Wei Zhang
2006
SLCO1B1 521T→C functional genetic polymorphism and lipid-lowering efficacy of multiple-dose pravastatin in Chinese coronary heart disease patients.
Zhang, W., B.L. Chen, V. Ozdemir, Y.J. He and G. Zhou et al.,
Br. J. Clin. Pharmacol., | Journal Article
10.1111/j.1365-2125.2007.02892.x
Self Wei Zhang
2006
Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide.
Zhang, W., Y.J. He, C.T. Han, Z.Q. Liu and Q. Li et al.,
Br. J. Clin. Pharmacol., | Journal Article
Self Wei Zhang
2006